123 related articles for article (PubMed ID: 26062064)
1. XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
Advani RH; Hoppe RT
Hematol Oncol; 2015 Jun; 33 Suppl 1():90-5. PubMed ID: 26062064
[No Abstract] [Full Text] [Related]
2. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
[No Abstract] [Full Text] [Related]
3. [IF-RT alone remains gold standard for stage IA nodular lymphocyte-predominant Hodgkin lymphoma].
Pilz K; Jentsch C; Krause M
Strahlenther Onkol; 2016 Jun; 192(6):428-30. PubMed ID: 27194138
[No Abstract] [Full Text] [Related]
4. [Diagnosis and treatment of nodular lymphocyte predominant Hodgkin lymphoma].
Nagai H
Nihon Rinsho; 2012 Apr; 70 Suppl 2():561-7. PubMed ID: 23134016
[No Abstract] [Full Text] [Related]
5. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.
Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R
Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195
[TBL] [Abstract][Full Text] [Related]
6. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
7. "Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease.
Carbone A; Gloghini A
Hum Pathol; 2012 May; 43(5):619-28. PubMed ID: 22209342
[TBL] [Abstract][Full Text] [Related]
8. The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
Büyükpamukçu M; Varan A; Akyüz C; Atahan L; Ozyar E; Kale G; Köksal Y; Kutluk T
Acta Oncol; 2009; 48(1):44-51. PubMed ID: 18777215
[TBL] [Abstract][Full Text] [Related]
9. Frontline management of nodular lymphocyte predominant Hodgkin lymphoma - a retrospective UK multicentre study.
Wilson MR; Bagguley T; Smith A; Roman E; Patmore R; Hanlon K; Leach M; Bishton M; Burton C; McKay P
Br J Haematol; 2019 Sep; 186(6):e214-e217. PubMed ID: 31344253
[No Abstract] [Full Text] [Related]
10. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Churchill HR; Roncador G; Warnke RA; Natkunam Y
Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
[TBL] [Abstract][Full Text] [Related]
11. Nodular lymphocyte predominant Hodgkin lymphoma.
Lee AI; LaCasce AS
Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
[TBL] [Abstract][Full Text] [Related]
12. Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness.
Szczepanowski M; Masqué-Soler N; Oschlies I; Schmidt W; Lück A; Klapper W
Hum Pathol; 2013 Jul; 44(7):1434-9. PubMed ID: 23427872
[TBL] [Abstract][Full Text] [Related]
13. T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.
Eyre TA; King AJ; Hatton C; Collins GP
Eur J Haematol; 2014 Jun; 92(6):550-1. PubMed ID: 24483596
[No Abstract] [Full Text] [Related]
14. Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins.
Cano I; Lozano M; Rodríguez A; Mate A; Adrados M; López Mdel M; Carro R; Montes-Moreno S
Histopathology; 2010 Jul; 57(1):159-62. PubMed ID: 20653789
[No Abstract] [Full Text] [Related]
15. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
16. Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).
Hartmann S; Eichenauer DA; Plütschow A; Mottok A; Bob R; Koch K; Bernd HW; Cogliatti S; Hummel M; Feller AC; Ott G; Möller P; Rosenwald A; Stein H; Hansmann ML; Engert A; Klapper W
Br J Haematol; 2014 Oct; 167(2):238-42. PubMed ID: 24965443
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
18. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
19. Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.
Goel A; Fan W; Patel AA; Devabhaktuni M; Grossbard ML
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):261-70. PubMed ID: 24650975
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors.
King RL; Howard MT; Bagg A
Adv Anat Pathol; 2014 Jan; 21(1):12-25. PubMed ID: 24316907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]